| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Özge Türkoğlu, Aygün Ertuğru. The Role of Cannabis in the Development of Psychosis. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 3. 2024-09-03. PMID:39224996. |
cannabis is known to cause psychotic disorders, and the increasing use of cannabis constitutes an important health problem. |
2024-09-03 |
2024-09-05 |
Not clear |
| Özge Türkoğlu, Aygün Ertuğru. The Role of Cannabis in the Development of Psychosis. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 3. 2024-09-03. PMID:39224996. |
keywords: cannabis abuse, psychotic disorders, schizophrenia, endocannabinoids, neurobiology. |
2024-09-03 |
2024-09-05 |
Not clear |
| Vera Brink, Humma Andleeb, Charlotte Gayer-Anderson, Celso Arango, Manuel Arrojo, Domenico Berardi, Miquel Bernardo, Julio Bobes, Cristina Marta Del-Ben, Laura Ferraro, Lieuwe de Haan, Daniele La Barbera, Caterina La Cascia, Antonio Lasalvia, Pierre-Michel Llorca, Paolo Rossi Menezes, Baptiste Pignon, Julio Sanjuán, José Luis Santos, Jean-Paul Selten, Ilaria Tarricone, Andrea Tortelli, Giada Tripoli, Eva Velthorst, Bart P F Rutten, Jim van Os, Diego Quattrone, Robin M Murray, Peter B Jones, Craig Morgan, Marta Di Forti, Hannah E Jongsma, James B Kirkbrid. The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study. Schizophrenia bulletin. 2024-05-24. PMID:38788048. |
the role of social deprivation and cannabis use in explaining variation in the incidence of psychotic disorders: findings from the eu-gei study. |
2024-05-24 |
2024-05-27 |
Not clear |
| Vera Brink, Humma Andleeb, Charlotte Gayer-Anderson, Celso Arango, Manuel Arrojo, Domenico Berardi, Miquel Bernardo, Julio Bobes, Cristina Marta Del-Ben, Laura Ferraro, Lieuwe de Haan, Daniele La Barbera, Caterina La Cascia, Antonio Lasalvia, Pierre-Michel Llorca, Paolo Rossi Menezes, Baptiste Pignon, Julio Sanjuán, José Luis Santos, Jean-Paul Selten, Ilaria Tarricone, Andrea Tortelli, Giada Tripoli, Eva Velthorst, Bart P F Rutten, Jim van Os, Diego Quattrone, Robin M Murray, Peter B Jones, Craig Morgan, Marta Di Forti, Hannah E Jongsma, James B Kirkbrid. The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study. Schizophrenia bulletin. 2024-05-24. PMID:38788048. |
recent findings suggest the incidence of first-episode psychotic disorders (fep) varies according to setting-level deprivation and cannabis use, but these factors have not been investigated together. |
2024-05-24 |
2024-05-27 |
Not clear |
| André J McDonald, Paul Kurdyak, Jürgen Rehm, Michael Roerecke, Susan J Bond. Age-dependent association of cannabis use with risk of psychotic disorder. Psychological medicine. 2024-05-22. PMID:38775165. |
age-dependent association of cannabis use with risk of psychotic disorder. |
2024-05-22 |
2024-05-27 |
Not clear |
| André J McDonald, Paul Kurdyak, Jürgen Rehm, Michael Roerecke, Susan J Bond. Age-dependent association of cannabis use with risk of psychotic disorder. Psychological medicine. 2024-05-22. PMID:38775165. |
epidemiologic research suggests that youth cannabis use is associated with psychotic disorders. |
2024-05-22 |
2024-05-27 |
Not clear |
| J P Selten, M Di Forti, D Quattrone, P B Jones, H E Jongsma, C Gayer-Anderson, A Szöke, P M Llorca, C Arango, M Bernardo, J Sanjuan, J L Santos, M Arrojo, I Tarricone, D Berardi, A Lasalvia, S Tosato, C la Cascia, E Velthorst, E M A van der Ven, L de Haan, B P Rutten, J van Os, J B Kirkbride, C M Morgan, R M Murray, F Termorshuize. The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe. Psychological medicine. 2024-05-09. PMID:38721761. |
we examined whether cannabis use contributes to the increased risk of psychotic disorder for non-western minorities in europe. |
2024-05-09 |
2024-05-27 |
Not clear |
| Martina Di Paolo, Antonia Calabrese, Guido Nosari, Valentina Ciappolino, Luisa Cirella, Alice Caldiroli, Enrico Capuzzi, Massimo Clerici, Massimiliano Buol. Clinical Variables and Peripheral Biomarkers Associated with Substance-Induced Psychotic Disorder: Differences Related to Alcohol, Cannabis, and Psychostimulant Abuse. Journal of personalized medicine. vol 14. issue 3. 2024-03-28. PMID:38541067. |
clinical variables and peripheral biomarkers associated with substance-induced psychotic disorder: differences related to alcohol, cannabis, and psychostimulant abuse. |
2024-03-28 |
2024-03-30 |
Not clear |
| H S van der Heijden, Martijn Kikkert, Lieuwe de Haan, Menno Segeren, Simone Molman, Frederike Schirmbeck, Jentien Vermeule. The relationship between substance use and self-reported aspects of social functioning in patients with a psychotic disorder. European psychiatry : the journal of the Association of European Psychiatrists. vol 67. issue 1. 2024-03-19. PMID:38418416. |
in patients with a psychotic disorder, rates of substance use (tobacco, cannabis, and alcohol) are higher compared to the general population. |
2024-03-19 |
2024-03-21 |
Not clear |
| Nicholas Fabiano, Saumil Dholakia, Lisa A S Walker, Andrew L Smit. Chronic high-dose dimenhydrinate use contributing to early multifactorial cognitive impairment. BMJ case reports. vol 17. issue 3. 2024-03-07. PMID:38453220. |
her clinical presentation was confounded by numerous other factors that could have impacted her cognition, such as a longstanding presumed learning disability, ankylosing spondylitis with adalimumab treatment, extensive cannabis use or potential development of a primary psychotic disorder. |
2024-03-07 |
2024-03-10 |
Not clear |
| Cerina Dubois, Carlotta Lunghi, Dean T Eurich, Jason R B Dyck, Elaine Hyshka, John G Hanlon, Arsene Zong. Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study. Schizophrenia research. vol 264. 2024-02-08. PMID:38330686. |
medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: a propensity score-matched cohort study. |
2024-02-08 |
2024-02-11 |
Not clear |
| Cerina Dubois, Carlotta Lunghi, Dean T Eurich, Jason R B Dyck, Elaine Hyshka, John G Hanlon, Arsene Zong. Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study. Schizophrenia research. vol 264. 2024-02-08. PMID:38330686. |
despite evidence showing that recreational cannabis use is associated with a higher risk of psychotic disorders, this risk has not been well characterized for patients using medical cannabis. |
2024-02-08 |
2024-02-11 |
Not clear |
| Cerina Dubois, Carlotta Lunghi, Dean T Eurich, Jason R B Dyck, Elaine Hyshka, John G Hanlon, Arsene Zong. Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study. Schizophrenia research. vol 264. 2024-02-08. PMID:38330686. |
therefore, this study assessed the risk of emergency department (ed) visits and hospitalization for psychotic disorders (the study outcome) among adult patients authorized to use medical cannabis. |
2024-02-08 |
2024-02-11 |
Not clear |
| Cerina Dubois, Carlotta Lunghi, Dean T Eurich, Jason R B Dyck, Elaine Hyshka, John G Hanlon, Arsene Zong. Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study. Schizophrenia research. vol 264. 2024-02-08. PMID:38330686. |
incidence rates for psychotic disorders were 3.00/1000 person-years (95%ci: 2.72-3.32) in the cannabis group and 1.88/1000 person-years (1.75-2.03) in the control group. |
2024-02-08 |
2024-02-11 |
Not clear |
| Cerina Dubois, Carlotta Lunghi, Dean T Eurich, Jason R B Dyck, Elaine Hyshka, John G Hanlon, Arsene Zong. Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study. Schizophrenia research. vol 264. 2024-02-08. PMID:38330686. |
the results suggest that cannabis authorization should include a benefit-risk assessment of psychotic disorders to minimize the risk of events requiring emergency attention. |
2024-02-08 |
2024-02-11 |
Not clear |
| Valerio Ricci, Ilenia Di Muzio, Franca Ceci, Francesco Di Carlo, Gianluca Mancusi, Tommaso Piro, Andrea Paggi, Mauro Pettorruso, Federica Vellante, Domenico De Berardis, Giovanni Martinotti, Giuseppe Main. Aberrant salience in cannabis-induced psychosis: a comparative study. Frontiers in psychiatry. vol 14. 2024-01-23. PMID:38260781. |
natural cannabis (nc) and synthetic cannabinoids (scs) use can increase the risk and exacerbate the course of psychotic disorders. |
2024-01-23 |
2024-01-25 |
Not clear |
| Gaurav Maggu, Swati Choudhary, Rajon Jaishy, Suprakash Chaudhury, Daniel Saldanha, Manish Boras. Cannabis use and its relationship with bipolar disorder: A systematic review and meta-analysis. Industrial psychiatry journal. vol 32. issue 2. 2024-01-01. PMID:38161465. |
cannabis use has been stated as a causal risk factor for the occurrence of schizophrenia and other psychotic disorders. |
2024-01-01 |
2024-01-05 |
Not clear |
| Matheus Wanderley de Medeiros, Julio Cesar Andrade, Natalia Mansur Haddad, Melina Mendonça, Leonardo Peroni de Jesus, Feten Fekih-Romdhane, Martinus Theodorus van de Bilt, Wagner Farid Gattaz, Alexandre Andrade Loc. Cannabis use influences disorganized symptoms severity but not transition in a cohort of non-help-seeking individuals at-risk for psychosis from São Paulo, Brazil. Psychiatry research. vol 331. 2023-12-19. PMID:38113810. |
cannabis use is associated with an increased risk of developing a psychotic disorder. |
2023-12-19 |
2023-12-23 |
Not clear |
| Johanna Manja Groening, Emma Denton, Rimsha Parvaiz, David Losada Brunet, Aisha Von Daniken, Yiling Shi, Sagnik Bhattacharyy. A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: An umbrella review of systematic reviews and meta-analyses. Psychiatry research. vol 331. 2023-12-14. PMID:38096722. |
an association between cannabis use and psychosis outcomes in patients with psychotic disorder could solely be confirmed regarding relapse. |
2023-12-14 |
2023-12-17 |
Not clear |
| Giulia Trotta, Victoria Rodriguez, Diego Quattrone, Edoardo Spinazzola, Giada Tripoli, Charlotte Gayer-Anderson, Tom P Freeman, Hannah E Jongsma, Lucia Sideli, Monica Aas, Simona A Stilo, Caterina La Cascia, Laura Ferraro, Daniele La Barbera, Antonio Lasalvia, Sarah Tosato, Ilaria Tarricone, Giuseppe D'Andrea, Andrea Tortelli, Franck Schürhoff, Andrei Szöke, Baptiste Pignon, Jean-Paul Selten, Eva Velthorst, Lieuwe de Haan, Pierre-Michel Llorca, Paulo Rossi Menezes, Cristina M Del Ben, Jose Luis Santos, Manuel Arrojo, Julio Bobes, Julio Sanjuán, Miquel Bernardo, Celso Arango, James B Kirkbride, Peter B Jones, Alexander Richards, Bart P Rutten, Jim Van Os, Isabelle Austin-Zimmerman, Zhikun Li, Craig Morgan, Pak C Sham, Evangelos Vassos, Chloe Wong, Richard Bentall, Helen L Fisher, Robin M Murray, Luis Alameda, Marta Di Fort. Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study. Psychological medicine. vol 53. issue 15. 2023-12-11. PMID:38078747. |
childhood adversity and cannabis use are considered independent risk factors for psychosis, but whether different patterns of cannabis use may be acting as mediator between adversity and psychotic disorders has not yet been explored. |
2023-12-11 |
2023-12-17 |
Not clear |